BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1903194)

  • 1. Structure and function of human jun-D.
    Berger I; Shaul Y
    Oncogene; 1991 Apr; 6(4):561-6. PubMed ID: 1903194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional control of SPARC by v-Jun and other members of the AP1 family of transcription factors.
    Vial E; Perez S; Castellazzi M
    Oncogene; 2000 Oct; 19(43):5020-9. PubMed ID: 11042689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse vimentin: structural relationship to fos, jun, CREB and tpr.
    Capetanaki Y; Kuisk I; Rothblum K; Starnes S
    Oncogene; 1990 May; 5(5):645-55. PubMed ID: 2140597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both Jun and Fos contribute to transcription activation by the heterodimer.
    Hirai S; Bourachot B; Yaniv M
    Oncogene; 1990 Jan; 5(1):39-46. PubMed ID: 2108402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of dimerization and DNA binding functions in Fos and Jun by domain-swapping: involvement of residues outside the leucine zipper/basic region.
    Cohen DR; Curran T
    Oncogene; 1990 Jun; 5(6):929-39. PubMed ID: 2113670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transactivation of the ApoCIII promoter by ATF-2 and repression by members of the Jun family.
    Hadzopoulou-Cladaras M; Lavrentiadou SN; Zannis VI; Kardassis D
    Biochemistry; 1998 Oct; 37(40):14078-87. PubMed ID: 9760243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter-specific trans-activation and inhibition mediated by JunB.
    Hsu JC; Cressman DE; Taub R
    Cancer Res; 1993 Aug; 53(16):3789-94. PubMed ID: 8339292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional analysis of the regulatory sequences of the ets-1 gene.
    Oka T; Rairkar A; Chen JH
    Oncogene; 1991 Nov; 6(11):2077-83. PubMed ID: 1945412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
    Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
    Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
    Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
    New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
    Hartl M; Bister K
    Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of the tissue inhibitor of metalloproteinases-1 promoter in culture-activated rat hepatic stellate cells: regulation by activator protein-1 DNA binding proteins.
    Bahr MJ; Vincent KJ; Arthur MJ; Fowler AV; Smart DE; Wright MC; Clark IM; Benyon RC; Iredale JP; Mann DA
    Hepatology; 1999 Mar; 29(3):839-48. PubMed ID: 10051488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner.
    Angel P; Smeal T; Meek J; Karin M
    New Biol; 1989 Oct; 1(1):35-43. PubMed ID: 2518690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
    Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
    Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. fos-jun Conspiracy: implications for the cell.
    Verma IM; Ransone LJ; Visvader J; Sassone-Corsi P; Lamph WW
    Princess Takamatsu Symp; 1989; 20():119-26. PubMed ID: 2518685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human ETS1 gene: genomic structure, promoter characterization and alternative splicing.
    Jorcyk CL; Watson DK; Mavrothalassitis GJ; Papas TS
    Oncogene; 1991 Apr; 6(4):523-32. PubMed ID: 2030910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man.
    Mattei MG; Simon-Chazottes D; Hirai S; Ryseck RP; Galcheva-Gargova Z; Guénet JL; Mattei JF; Bravo R; Yaniv M
    Oncogene; 1990 Jan; 5(1):151-6. PubMed ID: 2108401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jun DNA-binding is modulated by mutations between the leucines or by direct interaction of fos with the TGACTCA sequence.
    Hirai S; Yaniv M
    New Biol; 1989 Nov; 1(2):181-91. PubMed ID: 2562220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fli-1b is generated by usage of differential splicing and alternative promoter.
    Dhulipala PD; Lee L; Rao VN; Reddy ES
    Oncogene; 1998 Sep; 17(9):1149-57. PubMed ID: 9764825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus type 12 early region 1A expresses a 52R protein repressing the trans-activating activity of transcription factor c-Jun/AP-1.
    Brockmann D; Feng L; Kröner G; Tries B; Esche H
    Virology; 1994 Feb; 198(2):717-23. PubMed ID: 8291251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.